Cleveland, OH, United States of America

Dhiraj P Sonawane

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhiraj P Sonawane. Retrieved from https://idiyas.com/inventor/dhiraj-p-sonawane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dhiraj P. Sonawane and His Patent on Citron Kinase Inhibitors.

Introduction

Dhiraj P. Sonawane is an inventor associated with Cleveland, Ohio, and The Cleveland Clinic Foundation. His patent work concerns compounds that inhibit citron kinase, a research area with potential applications in cancer treatment.

Latest Patents

Sonawane is credited with 1 patent, titled “Citron Kinase Inhibitors.” The patent describes citron kinase-inhibiting compounds, pharmaceutical compositions containing them, and methods for using them. The disclosed methods include potential treatment of cancers such as medulloblastoma and prostate cancer.

Career Highlights

Sonawane’s listed invention connects his work at The Cleveland Clinic Foundation with pharmaceutical research focused on cancer. The patent describes possible therapeutic applications; it does not, by itself, establish that the compounds are approved treatments.

Collaborations

His listed coworkers include Shaun R. Stauffer and Jonathan D. Macdonald, reflecting a collaborative research environment at The Cleveland Clinic Foundation.

Conclusion

Dhiraj P. Sonawane’s patent documents research into citron kinase inhibitors and their potential use in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…